Journal of Histochemistry and Cytochemistry, Vol. 49, 919-920, July 2001, Copyright © 2001, The Histochemical Society, Inc.


BRIEF REPORT

Cytokeratin 20 Immunoreactivity in Renal Oncocytomas

Gary A. Stopyraa, Michael J. Warhola, and Hinke A.B. Multhaupta
a Department of Pathology, Pennsylvania Hospital, Philadelphia, Pennsylvania

Correspondence to: Hinke A.B. Multhaupt, Dept. of Pathology, Pennsylvania Hospital, 800 Spruce Street, Philadelphia, PA 19107. E-mail: himult@pahosp.com


  Summary
Top
Summary
Introduction
Literature Cited

Cytokeratins (CKs) are a group of 20 antigenically distinct intermediate filaments, generally confined to epithelia and their neoplasms. Immunostaining for CKs, in particular coordinate staining for CK7 and CK20, has become a useful tool in diagnostic pathology. Although studies defining CK distribution in neoplasms identify 0–7.7% of renal cell carcinomas (RCCs) positive for CK20, none has described the incidence of CK20 immunopositivity in renal oncocytomas (ROs). Distinction between RCC and RO may be difficult but this distinction is clinically significant, prompting us to establish the incidence of CK20 positivity in RO. We selected fifteen surgical cases of RO from our archives and studied their immunoreactivity for CKs including CK7 and CK20; 12/15 (80%) were positive for CK20, with variation in the number of cells staining. There was also variation in the distribution of CKs within the cells, including diffuse cytoplasmic, perinuclear, and a punctate or dot-like pattern. Such punctate staining corresponds to cytoplasmic balls of intermediate filaments and has been described with CAM 5.2 in RO and CK20 in Merkel cell carcinomas. Our findings suggest that CK20 immunohistochemistry is a useful tool for distinguishing RCCs from ROs. (J Histochem Cytochem 49:919–920, 2001)

Key Words: cytokeratins, renal cell carcinoma, renal oncocytoma, immunohistochemistry


  Introduction
Top
Summary
Introduction
Literature Cited

Immunohistochemical staining for intermediate filaments is widely used in the diagnosis of neoplasms whose origin is uncertain by routine light microscopy. One class of intermediate filaments are the cytokeratins (CKs), a group of 20 related yet antigenically distinct proteins that are generally confined to epithelia and neoplasms thereof (Moll et al. 1982 , Moll et al. 1992 ; Miettinen 1995 ). The expression of these 20 keratin subtypes varies in a relatively tissue specific manner in epithelial neoplasms, and the utility of coordinate staining for cytokeratins 7 and 20 in diagnostic pathology has been explored in recent literature (Wang et al. 1995 ; Multhaupt et al. 1999 ; Chu et al. 2000 ). In general, carcinomas of breast, lung, and ovary are CK71/CK202, carcinomas of the colon and Merkel cell carcinoma of skin are CK72/CK201, and pancreatobiliary, gastric, transitional cell, and some mucinous ovarian and colon carcinomas frequently co-express CK7 and CK20 (Moll et al. 1982 , Moll et al. 1992 ; Miettinen 1995 ; Wang et al. 1995 ; Multhaupt et al. 1999 ; Chu et al. 2000 ).Renal tubule neoplasms include renal cell carcinomas (RCCs), by definition malignant, and renal oncocytomas (ROs), which are benign (Amin et al. 1997 ). The distinction between these lesions is therefore significant. Oncocytoma cells demonstrate abundant eosinophilic cytoplasm due to abnormally numerous mitochondria that enlarge the cell. Unfortunately, subtypes of RCC may have a similar appearance. Molecular and ultrastructural studies that may distinguish RCC from RO are not always readily available, prompting the study of immunochemical methods of distinction.

Although studies describe an almost complete lack of CK20 positivity in RCC (Moll et al. 1992 ; Miettinen 1995 ; Wang et al. 1995 ; Chu et al. 2000 ), we are aware of no series studying the pattern of CK20 immunostaining in RO, prompting our investigation.

Fifteen cases of RO were selected from our files. Cases not definitively identified as oncocytomas were excluded. Tissue sections were formalin-fixed, paraffin-embedded, and stained with hematoxylin–eosin. All paraffin-embedded tissues were immunostained using the avidin–biotin–peroxidase technique with diaminobenzidine as a chromogen, on an automated immunostainer (Ventana ES; Ventana Medical Systems). We used antibodies against the following antigens: cytokeratin 7 (clone K72, prediluted; protease digestion; Ventana); cytokeratin 20 (clone K5 20.8, prediluted; protease digestion; Ventana); cytokeratins 8 and 18 (clone CAM 5.2, prediluted; protease digestion; Becton–Dickinson, San Jose, CA); and vimentin (clone V9, diluted 1:80; Biogenex, San Ramon, CA). All slides were counterstained with hematoxylin, dehydrated, and mounted. Microwave heat epitope retrieval was performed in a low-pH citrate buffer. A representative case was selected for ultrastructural study. Fresh tissue was fixed in 2.5% glutaraldehyde, then osmicated and processed for conventional embedding in Epon 812. Ultrathin sections were mounted on copper grids and stained with uranyl acetate followed by lead citrate before examination in a Philips CM10 electron microscope.

A total of 12/15 (80%) of cases were positive for CK20, 12/15 (80%) for CK7, 15/15 (100%) for CAM5.2, and 4/15 (27%) for vimentin. Regarding coordinate expression, 9/15 (60%) were CK7+/CK20+, 3/15 (20%) CK7+/CK20-, 3/15 (20%) CK7-/CK20+, and 0/15 (0%) were CK7-/CK20-. The extent of staining with all three antikeratins varied by case, ranging from less than 10% to over 80% of cells positive. In cases staining for vimentin, greater than 50% of cells were positive.

A peculiar variation in distribution of keratins was noted in the cells, including diffuse cytoplasmic staining, perinuclear rings, and punctate or dot-like staining (Fig 1A). One, two, or all three patterns were identified in individual cases. Noted in some cases was a zonal staining quality, i.e., regions of tumor demonstrated diffuse cytoplasmic staining, with other distinct regions showing the dot-like or the perinuclear pattern, possibly representing a clonal phenomenon. Vimentin-positive cases always showed a diffuse cytoplasmic pattern. Dot-like positivity for CAM 5.2 has been previously described to occur in 73% of ROs but in 0% of RCCs, and therefore if present distinguishes between these lesions (Bonsib et al. 1991 ). The staining corresponds to single large cytoplasmic condensations of intermediate filaments referred to as globular filamentous bodies (Fig 1B). Similar staining for CK20 is seen in Merkel cell carcinoma of skin (Miettinen 1995 ). Other benign and malignant neoplasms may demonstrate such aggregates, which vary in their intermediate filament composition (Bonsib et al. 1991 ). To our knowledge, these filament aggregates are decribed only in pathological processes; the molecular basis for their formation remains to be elucidated.



View larger version (158K):
[in this window]
[in a new window]
 
Figure 1. Renal oncocytoma. (A) Immunohistochemical staining for CK20, showing a dot-like pattern (hematoxylin counterstain). Original magnification x25. (B) Electron photomicrograph showing many mitochondria characteristic of oncocytoma and a cytoplasmic globular filamentous body adjacent to the nucleus. Original magnification x15,600.

Of the clear-cell, papillary, and chromophobe variants of RCC, the latter presents the greatest difficulty in diagnostic distinction from oncocytoma. The published series we have reviewed show from 0% to 7.7% of RCCs positive for CK20 (Moll et al. 1992 ; Miettinen 1995 ; Wang et al. 1995 ; Chu et al. 2000 ). Only one series provided the percent positivity of each variant (Moll et al. 1992 ). We hope to obtain examples of the chromphobe variant to study for CK20 expression.

Given the degree of CK20 positivity we have identified in RO and the low level of expression reported in RCC, we conclude that CK20 immunostaining is a useful diagnostic tool for distinguishing between these lesions.


  Footnotes

Presented in part at the Joint Meeting of the Histochemical Society and the International Society for Analytical and Molecular Morphology, Santa Fe, NM, February 2–7, 2001.

Received for publication December 8, 2000; accepted February 16, 2001.
  Literature Cited
Top
Summary
Introduction
Literature Cited

Amin MB, Crotty TB, Tickoo SK, Farrow GM (1997) Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 21:1-12[Medline]

Bonsib SM, Bromley C, Lager DJ (1991) Renal oncocytoma: diagnostic utility of cytokeratin-containing globular filamentous bodies. Mod Pathol 4:16-23[Medline]

Chu P, Wu E, Weiss L (2000) Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 13:962-972[Medline]

Miettinen M (1995) Keratin 20: immunohistochemical marker for gastrointestinal, urothelial and Merkel cell carcinomas. Mod Pathol 8:384-388[Medline]

Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24[Medline]

Moll R, Lowe A, Laufer J, Franke WW (1992) Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427-447[Abstract]

Multhaupt HAB, Arenas–Elliott CP, Warhol MJ (1999) Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. Arch Pathol Lab Med 123:909-916[Medline]

Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3:99-107





This Article
Abstract
Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Stopyra, G. A.
Articles by Multhaupt, H. A.B.
Articles citing this Article
PubMed
PubMed Citation
Articles by Stopyra, G. A.
Articles by Multhaupt, H. A.B.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]